Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

Clinical trial NCT00859131 · COMPLETED

Trial details

NCT number: NCT00859131
Sponsor: Medical University of South Carolina
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

End Stage Renal Disease

Start date: 2009-03-01
Primary completion: 2012-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.